• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    3/7/24 1:35:19 PM ET
    $ADT
    $AEYE
    $AGR
    $AISP
    Diversified Commercial Services
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADT alert in real time by email

    Shares of HighPeak Energy, Inc. (NASDAQ:HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.

    HighPeak Energy posted GAAP earnings of 66 cents per share, versus market estimates of 65 cents per share. The company’s quarterly sales came in at $301.153 million versus expectations of $339.525 million.

    HighPeak Energy shares declined 15.3% to $13.49 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) shares jumped 404% to $11.65 after the company announced the launch of Lytus Cloud.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) gained 167% to $6.81. CERo Therapeutics announced the publication in clinical cancer research a paper titled "Therapeutic Targeting of TIM-4-L With Engineered T CellsFor Acute Myeloid Leukemia."
    • Brera Holdings PLC (NASDAQ:BREA) shares climbed 97.5% to $2.0150 after the company announced that its Executive Chairman, Daniel McClory, acquired a majority stake in the company.
    • Grom Social Enterprises, Inc. (NASDAQ:GROM) gained 88.3% to $1.45. The company announced that it entered into a non-binding letter of intent to acquire Arctic7.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) rose 43% to $6.83. Creative Medical Technology announces FDA authorization for groundbreaking Type 1 diabetes prevention therapy under expanded access.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) gained 40.5% to $8.35 after the company received FDA Breakthrough Therapy Designation for its MM120 program in generalized anxiety disorder. The company also announced 12-week durability data from its Phase 2B study of MM120.
    • ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) jumped 34.2% to $2.1601 after the company announced that its subsidiary BioStrand developed a Foundation AI Model that uses Large Language Models Stacking and HYFT Technology.
    • Beneficient (NASDAQ:BENF) shares rose 28.7% to $0.1287. Beneficient agreed to the financing of liquidity transactions for three separate funds managed by ff Venture Capital.
    • MoneyLion Inc. (NYSE:ML) gained 28.3% to $67.43 following strong quarterly sales.
    • CompoSecure, Inc. (NASDAQ:CMPO) gained 27.5% to $5.99 as the company reported better-than-expected fourth-quarter financial results on Wednesday.
    • NexImmune, Inc. (NASDAQ:NEXI) rose 26% to $8.23.
    • Rush Street Interactive, Inc. (NYSE:RSI) gained 25.6% to $6.77 as the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for 2024.
    • OneSpan Inc. (NASDAQ:OSPN) climbed 24.9% to $11.97 after the company reported better-than-expected fourth-quarter financial results.
    • AirNet Technology Inc. (NASDAQ:ANTE) rose 24.7% to $1.51.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) climbed 23.2% to $41.35.
    • Ocean Biomedical, Inc. (NASDAQ:OCEA) gained 22.7% to $4.96.
    • Enhabit, Inc. (NASDAQ:EHAB) rose 21.9% to $9.58 following strong quarterly results.
    • Rentokil Initial plc (NYSE:RTO) gained 19.2% to $32.94 after the company reported better-than-expected FY23 financial results.
    • Wave Life Sciences Ltd. (NYSE:WVE) climbed 18.8% to $7.47. HC Wainwright & Co. analyst Andrew Fein maintained WAVE Life Sciences with a Buy and raised the price target from $8 to $15.
    • The Honest Company, Inc. (NASDAQ:HNST) rose 18.5% to $3.7301 after the company reported better-than-expected fourth-quarter financial results.
    • Dave Inc. (NYSE:DAVE) gained 18.2% to $37.38.
    • The Chemours Company (NYSE:CC) climbed 16.5% to $25.67.
    • Arhaus, Inc. (NASDAQ:ARHS) gained 15.2% to $14.77 following upbeat quarterly results.
    • AudioEye, Inc. (NASDAQ:AEYE) shares gained 13.8% to $7.89 after the company reported mixed fourth-quarter financial results and issued guidance.
    • Kronos Worldwide, Inc. (NYSE:KRO) climbed 13.5% to $9.82 following upbeat quarterly results.
    • Avangrid, Inc. (NYSE:AGR) gained 12.7% to $36.15 after the company announced that the Unaffiliated Committee of its Board of Directors received a non-binding proposal from Iberdrola to acquire all common shares that it or its affiliates do not own for $34.25 in cash per share.
    • E2open Parent Holdings, Inc. (NYSE:ETWO) gained 10.5% to $4.4750. E2open announced initiation of a strategic review.
    • Avinger, Inc. (NASDAQ:AVGR) shares rose 8.8% to $4.0252 after the company entered into strategic partnership and up to $15 million equity funding agreement with Zylox-Tonbridge to access Greater China market.
    • The Kroger Co. (NYSE:KR) gained 6.9% to $53.99 after the company reported fourth-quarter EPS above estimates.
    • Yext, Inc. (NYSE:YEXT) shares gained 6.1% to $6.32 after the company reported better-than-expected fourth-quarter financial results.

    Losers

    • Solowin Holdings (NASDAQ:SWIN) fell 31.6% to $32.12 after jumping 135% on Wednesday.
    • MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) dipped 30.7% to $0.5266.
    • Victoria's Secret & Co. (NYSE:VSCO) dipped 30.1% to $17.90 after reporting fourth-quarter results.
    • Methode Electronics, Inc. (NYSE:MEI) fell 28.7% to $15.00 following weak quarterly results.
    • Nature Wood Group Limited (NASDAQ:NWGL) fell 27.1% to $13.60.
    • Aptorum Group Limited (NYSE:APM) shares fell 27.1% to $6.92. Aptorum shares jumped 468% on Wednesday after the company announced it entered into an agreement and plan of merger with YOOV and also announced a spin-off agreement to separate its legacy business.
    • Avid Bioservices, Inc. (NASDAQ:CDMO) shares fell 25.9% to $6.51 after the company reported certain preliminary third-quarter financial results and announced a proposed $160 million private placement of convertible notes.
    • Airship AI Holdings, Inc. (NASDAQ:AISP) fell 25.1% to $5.18. Airship AI Holdings filed amended S-1 registration statement.
    • CNFinance Holdings Limited (NYSE:CNF) fell 24.6% to $1.7559.
    • Emergent BioSolutions Inc. (NYSE:EBS) fell 21.5% to $2.56 after posting weak quarterly results.
    • Enviva Inc. (NYSE:EVA) shares tumbled 15.6% to $0.7950 after surging over 27% on Wednesday.
    • Viking Therapeutics, Inc. (NASDAQ:VKTX) fell 15% to $77.40. Jefferies analyst Roger Song initiated coverage on Viking Therapeutics with a Buy rating and announced a price target of $110.
    • Hudson Technologies, Inc. (NASDAQ:HDSN) fell 15% to $12.08 following fourth-quarter results.
    • Ciena Corporation (NYSE:CIEN) dipped 13.8% to $53.40 after the company reported first-quarter revenue decline.
    • TriplePoint Venture Growth BDC Corp. (NYSE:TPVG) declined 13% to $9.46 after the company reported worse-than-expected fourth-quarter financial results.
    • Stevanato Group S.p.A. (NYSE:STVN) fell 10.3% to $29.70 following fourth-quarter results.
    • ADT Inc. (NYSE:ADT) shares fell 8.9% to $6.81 as the company reported pricing of secondary public offering of common stock and concurrent share repurchase.

    Now Read This: How To Earn $500 A Month From Broadcom Ahead Of Q1 Earnings Report

    Get the next $ADT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADT
    $AEYE
    $AGR
    $AISP

    CompanyDatePrice TargetRatingAnalyst
    Viking Therapeutics Inc.
    $VKTX
    3/26/2026Peer Perform
    Wolfe Research
    Rush Street Interactive Inc.
    $RSI
    3/26/2026$26.00Overweight
    Wells Fargo
    Ciena Corporation
    $CIEN
    3/12/2026$425.00Buy
    TD Cowen
    Rentokil Initial plc
    $RTO
    3/12/2026Neutral → Buy
    UBS
    Yext Inc.
    $YEXT
    3/11/2026$6.00Buy → Neutral
    Roth Capital
    Rentokil Initial plc
    $RTO
    3/11/2026Sell → Neutral
    Rothschild & Co Redburn
    Enhabit Inc.
    $EHAB
    3/6/2026$13.80Buy → Hold
    TD Cowen
    ADT Inc.
    $ADT
    3/6/2026$7.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $ADT
    $AEYE
    $AGR
    $AISP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Viking Therapeutics

    Wolfe Research initiated coverage of Viking Therapeutics with a rating of Peer Perform

    3/26/26 9:00:52 AM ET
    $VKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wells Fargo initiated coverage on Rush Street Interactive with a new price target

    Wells Fargo initiated coverage of Rush Street Interactive with a rating of Overweight and set a new price target of $26.00

    3/26/26 8:51:46 AM ET
    $RSI
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    TD Cowen initiated coverage on Ciena with a new price target

    TD Cowen initiated coverage of Ciena with a rating of Buy and set a new price target of $425.00

    3/12/26 8:50:16 AM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    $ADT
    $AEYE
    $AGR
    $AISP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hudson Technologies Signs Licensing Agreement with Solstice Advanced Materials for the Reclamation and Resale of Patented HFO Refrigerants

    WOODCLIFF LAKE, N.J., March 27, 2026 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ:HDSN) ("Hudson"; "the Company") a leading provider of innovative and sustainable refrigerant products and services to the Heating, Ventilation, Air Conditioning and Refrigeration Industry – and one of the nation's largest refrigerant reclaimers – announces that it has signed a licensing agreement with Solstice Advanced Materials (NASDAQ:SOLS) for the reclamation and resale of R-448A and R-449A refrigerants. These patented HFO refrigerant blends are two of the leading alternative refrigerants used in accordance with the AIM Act when replacing higher GWP HFC refrigerants with lower GWP HFO refrigerant

    3/27/26 8:30:00 AM ET
    $HDSN
    $SOLS
    Industrial Specialties
    Consumer Discretionary
    Aerospace
    Industrials

    Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

    At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p<0.05) and total fat (-5%), stabilization of lean mass (+2%), and reductions in waist circumference (-3%) and body weight (-1%) WVE-007 led to greater improvement in body composition (visceral fat-to-muscle ratio) at six months versus that seen with weekly GLP-1 in later-stage trial (BMI: ~37 kg/m2), even with participants in Phase 1 portion of INLIGHT™ having substantially lower BMI (~32 kg/m2) and lower levels of fat than those in Phase 2 and 3 obesity studies Phase 2a portion of INLIGHT in individuals with higher BMI (35-50 kg/m2)

    3/26/26 7:30:00 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735

    78-Week Study Evaluating Subcutaneous VK2735 in Adults with Obesity and Type 2 DiabetesSAN DIEGO, March 26, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of patient enrollment in its Phase 3 VANQUISH-2 clinical trial of subcutaneous VK2735, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. VK2735 is being developed in both oral and subcutaneous formulations for the potential treatment of metabolic disorders such as obesity.

    3/26/26 7:05:00 AM ET
    $VKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $AEYE
    $AGR
    $AISP
    SEC Filings

    View All

    SEC Form 20-F filed by Aptorum Group Limited

    20-F - Aptorum Group Ltd (0001734005) (Filer)

    3/27/26 4:02:32 PM ET
    $APM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Yext Inc.

    SCHEDULE 13G/A - Yext, Inc. (0001614178) (Subject)

    3/27/26 2:17:00 PM ET
    $YEXT
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Victorias Secret & Co.

    SCHEDULE 13G/A - Victoria's Secret & Co. (0001856437) (Subject)

    3/27/26 1:53:51 PM ET
    $VSCO
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ADT
    $AEYE
    $AGR
    $AISP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Xu Lin 1962

    3 - CNFinance Holdings Ltd. (0001733868) (Issuer)

    3/26/26 8:15:58 PM ET
    $CNF
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Takanashi Ken

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    3/26/26 4:15:13 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Gage Brodie

    4 - CIENA CORP (0000936395) (Issuer)

    3/25/26 6:43:06 PM ET
    $CIEN
    Telecommunications Equipment
    Utilities

    $ADT
    $AEYE
    $AGR
    $AISP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF FINANCIAL OFFICER Georgevich Kelly bought $99,398 worth of shares (16,850 units at $5.90), increasing direct ownership by 13% to 144,981 units (SEC Form 4)

    4 - AUDIOEYE INC (0001362190) (Issuer)

    3/17/26 4:35:45 PM ET
    $AEYE
    Computer Software: Prepackaged Software
    Technology

    Director Hawkins James B bought $219,744 worth of shares (38,000 units at $5.78), increasing direct ownership by 22% to 207,517 units (SEC Form 4)

    4 - AUDIOEYE INC (0001362190) (Issuer)

    3/12/26 4:20:55 PM ET
    $AEYE
    Computer Software: Prepackaged Software
    Technology

    EVP, Chief People & Admin. Off Scott David A. bought $49,056 worth of shares (7,300 units at $6.72) (SEC Form 4)

    4 - ADT Inc. (0001703056) (Issuer)

    3/9/26 5:28:50 PM ET
    $ADT
    Diversified Commercial Services
    Consumer Discretionary

    $ADT
    $AEYE
    $AGR
    $AISP
    Leadership Updates

    Live Leadership Updates

    View All

    Beneficient Appoints Mack H. Hicks to Board of Directors

    DALLAS, March 12, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced the appointment of Mack H. Hicks as a member of the Company's Board of Directors (the "Board"). Mr. Hicks currently serves as Chief Executive Officer of Hicks Holdings LLC, the Dallas-based family office with operating private equity and real estate investment businesses founded by his late father and private equity pioneer, Thomas O. Hicks, who served as Chairman of the Board of Beneficient until his passing in December of 2025. Mr. Hicks also

    3/12/26 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    CERo Therapeutics Provides Shareholder Update

    Ongoing activities, including new engagement to relist on Nasdaq, new board member, continued advancement of Phase 1 trial into MDS patients, strategic engagement, and continued support from lead investor, underscore the Company's operational momentum SOUTH SAN FRANCISCO, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, provides an update through the letter to stockholders and stakeholders from CEO Chris Ehrlich: To our stockholders and stakeholders: Following our recent Form 8-K filing confirming receipt of convertible deb

    3/11/26 8:15:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tim Johnson Nominated to Join Amaero Board

    MCDONALD, Tenn., March 10, 2026 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTC:AMROF) ("Amaero" or the "Company"), a leading U.S. domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to announce that Tim "TJ" Johnson has been nominated to join Amaero's Board as a Non-Executive Director, subject to satisfying the requisite regulatory requirements. Upon joining the Board as a Non-Executive Director, it is anticipated that he will assume the responsibilities of Chairman of the Audit and Risk Committee. Mr. Johnson is an experienced corporate board member

    3/10/26 8:00:00 AM ET
    $DLTR
    $DRVN
    $EAT
    Department/Specialty Retail Stores
    Consumer Discretionary
    Automotive Aftermarket
    Restaurants

    $ADT
    $AEYE
    $AGR
    $AISP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Avid Bioservices Inc.

    SC 13G - Avid Bioservices, Inc. (0000704562) (Subject)

    12/13/24 10:53:25 AM ET
    $CDMO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by MoneyLion Inc.

    SC 13D/A - MONEYLION INC. (0001807846) (Subject)

    12/10/24 5:27:46 PM ET
    $ML
    Finance: Consumer Services
    Finance

    $ADT
    $AEYE
    $AGR
    $AISP
    Financials

    Live finance-specific insights

    View All

    Hudson Technologies Signs Licensing Agreement with Solstice Advanced Materials for the Reclamation and Resale of Patented HFO Refrigerants

    WOODCLIFF LAKE, N.J., March 27, 2026 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ:HDSN) ("Hudson"; "the Company") a leading provider of innovative and sustainable refrigerant products and services to the Heating, Ventilation, Air Conditioning and Refrigeration Industry – and one of the nation's largest refrigerant reclaimers – announces that it has signed a licensing agreement with Solstice Advanced Materials (NASDAQ:SOLS) for the reclamation and resale of R-448A and R-449A refrigerants. These patented HFO refrigerant blends are two of the leading alternative refrigerants used in accordance with the AIM Act when replacing higher GWP HFC refrigerants with lower GWP HFO refrigerant

    3/27/26 8:30:00 AM ET
    $HDSN
    $SOLS
    Industrial Specialties
    Consumer Discretionary
    Aerospace
    Industrials

    Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007

    At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p<0.05) and total fat (-5%), stabilization of lean mass (+2%), and reductions in waist circumference (-3%) and body weight (-1%) WVE-007 led to greater improvement in body composition (visceral fat-to-muscle ratio) at six months versus that seen with weekly GLP-1 in later-stage trial (BMI: ~37 kg/m2), even with participants in Phase 1 portion of INLIGHT™ having substantially lower BMI (~32 kg/m2) and lower levels of fat than those in Phase 2 and 3 obesity studies Phase 2a portion of INLIGHT in individuals with higher BMI (35-50 kg/m2)

    3/26/26 7:30:00 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Methode Electronics' Board Approves Dividend

    SOUTHFIELD, Mich., March 18, 2026 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE:MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, announced today that its board of directors has declared a quarterly dividend of $0.05 per share to be paid on May 1, 2026, to common stockholders of record at the close of business on April 17, 2026. About Methode Electronics, Inc.Methode Electronics, Inc. (NYSE:MEI) is a leading global supplier of custom-engineered solutions with sales, engineering and manufacturing locations in North America, Europe, Middle East and Asia. We design, engineer, and produce mechatronic product

    3/18/26 4:11:00 PM ET
    $MEI
    Electrical Products
    Technology